Working groups
Michelle is a Paediatrician and International health specialist experienced in health system strengthening, health worker training, maternal, newborn and child health, and implementation research. She is also a Principal Investigator on Burnet’s flagship Healthy Mothers, Healthy Babies (HMHB) program based in East New Britain, Papua New Guinea (PNG), and a PhD candidate.
Whilst Michelle was the Research Program Manager for HMHB based in East New Britain, she established the HMHB field site which included the cementing of all key partnerships, the establishment of a physical office, the building of a research laboratory and the hiring, training, and management of an administrative and technical research team. She managed the successful completion of a large longitudinal cohort study, which is the first of its kind in PNG, following women and their infant from early pregnancy through to twelve months postpartum.
Michelle’s research focuses on improving poor newborn and child growth, especially in PNG, and understanding how nutrition and infection in pregnancy impacts on infant health.
Michelle’s clinical work currently focuses on caring for children and young people with long COVID, and together with Dr Suman Majumdar, Dr Emma Tippett and a team of collaborators, she has received funding from the Medical Research Future Fund to pursue this important area of research.
Internal Medicine Journal
Michelle J. L. Scoullar, Emma Tippett
Vaccines
Milena Dalton, Caroline Homer, Benjamin M. Sanderson, Leanne J. Robinson, Michelle J. L. Scoullar, Stefanie Vaccher
The Medical Journal of Australia
Michelle J. L. Scoullar, Gabriela Khoury, S. S. Majumdar, Emma Tippett, Brendan S. Crabb
A collaborative research program aimed at providing life-saving health care for women and children in Papua New Guinea.
In resource-poor regions, pregnant women experience high malaria rates, undernutrition and sexually transmitted infections. These can lead to maternal morbidity, mortality and in infants low birth weight and stunting.
HEAL APT: Harnessing effective approaches for long COVID therapies through an adaptive platform trial.
More than 2.7 million babies die within the first 28 days of life worldwide, and we're working to reduce these deaths through postnatal care.
This project compares the performance of novel high sensitivity Plasmodium falciparum rapid diagnostic tests with conventional tests.